ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

MENOMUNE-A/C/Y/W-135
Vaccines
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

MENOMUNE-A/C/Y/W-135 Rx

Generic Name and Formulations:
Neisseria meningitidis polysaccharides 50mcg; each of Group A, C, Y, and W-135 per 0.5mL; pwd for SC inj after reconstitution.

Company:
Sanofi Pasteur, Inc.

Therapeutic Use:

Indications for MENOMUNE-A/C/Y/W-135:

Meningitis immunization.

Adults and Children:

<2yrs: not recommended (except as short-term protection in infants ≥3months of age against Group A). ≥2yrs: 0.5 mL SC once. If still at high risk, may revaccinate children first vaccinated at <4yrs of age after 2–3yrs, and older children and adults after 3–5yrs.

Contraindications:

Acute illness.

Warnings/Precautions:

Immunodeficiency. Have epinephrine inj (1:1000) available. Latex allergy. Pregnancy (Cat.C). Nursing mothers.

Interactions:

Do not give with whole-cell pertussis or whole-cell typhoid vaccines. Immunosuppressants: may get suboptimal response.

Adverse Reactions:

Tenderness, erythema, or pain at inj site; headache, malaise, chills, fever.

How Supplied:

Single-dose vials—1, 5 (preservative-free diluent); Multidose vial—1 (thimerosal-preserved diluent)

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs